Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...

The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals ...

Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...

The ZenoTOF 8600 system was used to measure the bile acid content of human plasma sample extracts using both CID- and ...